The term “secondary TDP-43 proteinopathy” refers to the detection of pathological species of TDP-43 in other neurodegenerative diseases, in which TDP-43 is expected to play a part, either pathogenic or reactive, in response to the corresponding primary proteinopathy. This evidence concerns the gene TARDBP and neurodegenerative disease.